SCHEMBL26419478

SCHEMBL26419478

CC1CN(C2CCC(OC(C)(C)C)CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24853992 0.83 — —
SCHEMBL24995328 0.82 IRAK4 (0.31) —
SCHEMBL26421943 0.82 — —
SCHEMBL24827822 0.82 — —
SCHEMBL26419402 0.82 — —
SCHEMBL25935464 0.79 — —
SCHEMBL18032457 0.78 L3MBTL3 (0.35) —
SCHEMBL26419480 0.78 ABCB1 (0.33) —
SCHEMBL16205340 0.78 — —
SCHEMBL22704068 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128824-A1 SPIRO RING-CONTAINING QUINAZOLINE COMPOUND Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2023-04-27 — — US disclosed
Send feedback